LaVoieHealthScience

LaVoieHealthScience

Advancing Health & Science Innovations Through Strategic Communications

One Thompson Square, Suite 503, Boston, Massachusetts 02129, United States

LaVoieHealthScience Overview

Number of Employees
Under 49
Minimal Budget
Inquire
Average Hourly Rate
Inquire
Year Founded
2001
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, access and marketing. With two decades of industry-tested counsel to more than 375 clients, we provide strategic consulting, investor relations, and public relations to build recognition and increase sales and value for health science innovations

The agency has received over 50 awards in recognition of the work it has done helping health and science innovators, from development to launch and commercialization, to connect with key stakeholders. We provide specialized thinking to clients throughout the company and product life cycle, and offer direct connections to media, investors, partners, advocacy groups, and KOLs. We are focused on building trust and long-term relationships based on the quality of the work that we deliver.

In January 2020, LHS and Omnicom Public Relations Group (OPRG), a division of Omnicom Group (NYSE: OMC), formed a strategic alliance to bring global clients a broader set of integrated health- and science-experienced teams. LHS also formed an alliance with Bioscience Valuation BSV GmbH in June 2020 that combines LHS’ expertise in strategic communications for companies at the forefront of health and science innovation with BSV’s skill in providing strategic valuation assessments for life science companies.
Headquarters
One Thompson Square, Suite 503, Boston, Massachusetts 02129, United States

LaVoieHealthScience Clients

  • AC Immune SA
  • Biotechnology Innovation Organization
  • Landos Biopharma
  • LEO Science & Tech Hub
  • Newron Pharmaceuticals
  • Pathmaker Neurosystems
  • SIRION Biotech
  • Symbiotix Biotherapies, Inc.
  • Triumvera Immunologics
  • Xontogeny LLC